David Siegel, MD
Medical Oncology · Hackensack, NJNPI 1457310815
Payments from drug & device makers
Across 393 payments — averaging $17,456 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$4.5M
- Amgen$755K
- E.r. Squibb & Sons, L.L.C.$735K
- Merck$576K
- Janssen Research & Development, LLC$88K
- Karyopharm Therapeutics Inc.$52K
- plus $176K from 23 others
Across 16 payments — averaging $2301.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$29K
- Bristol Myers Squibb$7K
- Regeneron$179
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 103 | $4,477,994 |
| Amgen | 64 | $755,388 |
| E.r. Squibb & Sons, L.L.C. | 32 | $735,038 |
| Merck | 15 | $575,762 |
| Janssen Research & Development, LLC | 30 | $87,699 |
| Karyopharm Therapeutics Inc. | 20 | $52,238 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $47,978 |
| GSK | 18 | $45,026 |
| Regeneron | 4 | $29,502 |
| Seagen Inc. | 3 | $9,200 |
| Johnson & Johnson | 23 | $8,812 |
| Janssen Global Services, LLC | 8 | $8,470 |
| Pharmacyclics LLC, An Abbvie Company | 6 | $6,274 |
| Celularity Inc. | 2 | $6,000 |
| Pfizer | 12 | $3,699 |
| Sanofi | 7 | $3,319 |
| F. Hoffmann-la Roche AG | 2 | $3,095 |
| Genentech, Inc. | 2 | $2,045 |
| Taiho Oncology, Inc. | 1 | $1,800 |
| Menarini Silicon Biosystems, Inc. | 1 | $500 |
| AstraZeneca | 2 | $125 |
| Adaptive Biotechnologies Corporation | 2 | $120 |
| Legend Biotech USA Inc. | 1 | $91 |
| AbbVie | 3 | $52 |
| Sanofi-aventis U.S. LLC | 1 | $26 |
| Secura Bio, Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Beigene USA, Inc. | 1 | $15 |
| Cornerstone Specialty Network LLC | 10 | $0 |
How this compares
$6,860,302 in reported general payments places this provider in the 90th percentile of 112 medical oncology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Hackensack
- Martin GutierrezHackensack$41.8M
- James McCloskeyHackensack$17.1M
- Lori LeslieHackensack$11.9M
- Tatyana FeldmanHackensack$8.4M
- Noa BiranHackensack$5.8M
- Andrew PecoraHackensack$4.5M
- Robert AlterHackensack$4.5M
- Jamie KoprivnikarHackensack$3.8M
- David VesoleHackensack$3M
- Deena GrahamHackensack$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.